Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crown Castle International Corp (CCI) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Crown Castle International CorpTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Crown Castle International Corp vs State Street SPDR S&P Biotech ETF — how do they compare? Crown Castle International Corp trades at $79.05 (market cap $34.85B), while State Street SPDR S&P Biotech ETF trades at $155.51. The key difference: Crown Castle International Corp pays a 5.32% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Crown Castle International Corp nearer its low. Which is the better fit depends on your goals.

CCIXBI
Market Cap
$34.85B
Sector
Real EstateBroad Market / Factor
52-Week High
$113.91$164.28
52-Week Low
$74.92$85.16
Enterprise Value
$64.67B
Dividend Yield
5.32%

Returns comparison

Trailing returns across standard periods

About Crown Castle International Corp

Crown Castle International owns and leases roughly 40,000 cell towers in the United States. It also owns more than 85,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company's fiber is primarily leased by wireless service providers to set up small-cell network infrastructure and by enterprises for their internal connection needs. Crown Castle's towers and fiber are predominantly located in the largest U.S. cities. The company has a very concentrated customer base, with more than 70% of its revenue coming from the big three U.S. mobile carriers. Crown Castle operates as a real estate investment trust.

Read more on CCI

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI